Risk model with six parameters predicts outcome in patients with metastatic cancers of different origins receiving immune checkpoint inhibitors. Risk model with six parameters predicts outcome in patients with metastatic cancers of different origins receiving immune checkpoint inhibitors.
Risk model identifies metastatic cancer patients who may benefit from immune checkpoint inhibitors medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.